Popular on TelAve
- FirstFruits Farms and Opal Partner with the Junior Basketball League to Empower Youth Through Nutrition and Sport
- Peachtree Immediate Care Opens Two New Locations in December
- Webinar Announcement: Navigating the New Investment Adviser AML Mandate: What Steps Should Investment Advisers Be Taking Now?
- Industry-Changing Multi-Benefit Service Platform for Technology Systems & AI Smart Devices Drives; 218% Revenue Growth for Tekumo: Stock Symbol: TKMO
- Somebody's Husband by Robbi Renee Earns Early Acclaim for Its Powerful Exploration of Love, Loss, and Healing
- OmegaBrand Introduces New Thermal Transfer Ribbons for Honeywell PC45t Printers
- Texas Center For Oral Surgery & Dental Implants Launches Redesigned Website to Enhance Patient Experience
- New Age of Law Firm Website Design
- Stan Fitzgerald: A Profile in Resilience and Leadership with VFAF Veterans for America First Organizational Support for a Presidential Pardon
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Similar on TelAve
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- Acmeware and Interlace Health Join Forces to Revolutionize Downtime Solutions
- Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
- Paris Hilton, Congress Praised for Teen Behavioral Treatment Abuse Prevention
CURE Childhood Cancer Secures Record Funding for Research
TelAve News/10839855
Organization Receives Vital Support from Hyundai Hope On Wheels®
SAVANNAH, Ga. - TelAve -- CURE Childhood Cancer, a leading non-profit dedicated to conquering childhood cancer through funding targeted research and supporting local patients and their families, has awarded a record-breaking $5.6 million investment in research grants for its 2024-2025 fiscal year.
The grants have been awarded to top scientists at leading pediatric cancer research institutions across the nation and represent CURE's highest disbursement in a single grant cycle. This brings CURE's total investment in research over the last 18 years to more than $50 million. CURE is awarding two-year grants in both its Early Investigators and Translation to CURE Award groupings.
"We are so pleased and proud that CURE is providing an outstanding level of support to very promising research this year," said Kristin Connor, CEO of CURE Childhood Cancer. "We are funding two-year grants so researchers can focus on finding cures rather than finding funding. All of the grants aim to make better-tolerated and less-toxic therapies, with a special emphasis on relapsed and refractory disease where current treatments are quite noxious and often not very effective for children."
More on TelAve News
This year, CURE is also proud to acknowledge the crucial role of donors like Hyundai Hope On Wheels®, which donated $45,000 toward CURE Childhood Cancer's South Georgia Family Emergency assistance.
"By partnering with CURE Childhood Cancer, the organization is helping to provide vital support to families in Georgia facing immediate needs due to their child's cancer diagnosis, such as housing, transportation, and medical expenses not covered by insurance," said John Guastaferro, Executive Director of Hyundai Hope On Wheels Foundation. "This is right in line with our commitment to making a tangible impact on the lives of children battling cancer."
"This incredibly generous donation is our largest grant in the South Georgia area to date," said Mandy Garola, Vice President of CURE Childhood Cancer in South Georgia. "Hyundai Hope On Wheels' support is a prime example of how generous donors like them enable us to provide crucial support to our families while also funding groundbreaking research."
CURE's funding decisions are guided by its Peer Review Committee, a group of practicing oncologists and academic scientists who conduct a rigorous review of more than 50 proposals to assess both scientific merit and alignment with CURE's goals. Of those proposals, CURE selected 11 studies to fund, most of which offer hope of testing more effective treatments for childhood cancers with poor prognosis within 2-3 years.
To learn more visit https://www.curechildhoodcancer.org.
The grants have been awarded to top scientists at leading pediatric cancer research institutions across the nation and represent CURE's highest disbursement in a single grant cycle. This brings CURE's total investment in research over the last 18 years to more than $50 million. CURE is awarding two-year grants in both its Early Investigators and Translation to CURE Award groupings.
"We are so pleased and proud that CURE is providing an outstanding level of support to very promising research this year," said Kristin Connor, CEO of CURE Childhood Cancer. "We are funding two-year grants so researchers can focus on finding cures rather than finding funding. All of the grants aim to make better-tolerated and less-toxic therapies, with a special emphasis on relapsed and refractory disease where current treatments are quite noxious and often not very effective for children."
More on TelAve News
- NuNorm Announces Stop Soldier Suicide as This Year's EQUAL Grant Recipient
- Darrin Jones: The Creative Force Behind the Trends—Raising Questions About Influence in The Weeknd's Music
- Foresight Practitioner Conference 2025 – Dates, Venue, Speakers, And Competition Finalists Announced
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- Best Plant Varieties for Windbreaks and Shelterbelts
This year, CURE is also proud to acknowledge the crucial role of donors like Hyundai Hope On Wheels®, which donated $45,000 toward CURE Childhood Cancer's South Georgia Family Emergency assistance.
"By partnering with CURE Childhood Cancer, the organization is helping to provide vital support to families in Georgia facing immediate needs due to their child's cancer diagnosis, such as housing, transportation, and medical expenses not covered by insurance," said John Guastaferro, Executive Director of Hyundai Hope On Wheels Foundation. "This is right in line with our commitment to making a tangible impact on the lives of children battling cancer."
"This incredibly generous donation is our largest grant in the South Georgia area to date," said Mandy Garola, Vice President of CURE Childhood Cancer in South Georgia. "Hyundai Hope On Wheels' support is a prime example of how generous donors like them enable us to provide crucial support to our families while also funding groundbreaking research."
CURE's funding decisions are guided by its Peer Review Committee, a group of practicing oncologists and academic scientists who conduct a rigorous review of more than 50 proposals to assess both scientific merit and alignment with CURE's goals. Of those proposals, CURE selected 11 studies to fund, most of which offer hope of testing more effective treatments for childhood cancers with poor prognosis within 2-3 years.
To learn more visit https://www.curechildhoodcancer.org.
Source: Cecilia Russo Marketing
0 Comments
Latest on TelAve News
- Top Book Printer in Central Ohio announces expansion
- Comp-U-Floor ERP to Showcase All-in-One Flooring Software at TISE 2025
- "Cannabis Industry Dream Team" Launches GreenFlow Systems to Revolutionize Manufacturing Standards
- Pawganja Token: Redefining Cryptocurrency with Transparency and Philanthropy
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- Upgraded Emergency Tech Keeps Owensboro Health Ahead During Winter Storm
- The Best Places to Go in Mexico in 2025
- Nayarit: Mexico's Best-Kept Secret for Fall and Winter Getaways in 2025
- LIB: A master of ingenuity in the field of custom test chambers, unlocking unlimited possibilities!
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
- Cyrus Webb and Conversations Media Group Providing New Opportunities for Authors and Creatives to Shine and Thrive
- Inframark Acquires Cornerstone Properties, Inc., Expanding Community Management Services in Arizona
- Alyrica Networks Approved as Oregon Lifeline Provider, Offering Affordable High-Speed Internet to Low-Income Households
- Transform Warehouse Operations: Redefining Logistics with Customized Solutions
- NaturismRE Introduces Global Accreditation Standards to Redefine Nudist and Naturist Venues
- Enhancing Campus Safety for Women: The Blue Luna's New Initiative
- More high-priority SIGINT solutions were announced for Krypto1000 SIGINT software
- SCOPY.ME - Revolutionizes Business Strategy Development with AI-Powered Platform
- TimelyBill to Showcase Innovation at ITEXPO
- Moonshot Announces 6th Annual 2025 Rural Arizona Pitch Competition Tour with Bilingual Resources and Mentors